Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp expected to post a loss of 45 cents a share - Earnings Preview

* Pulmonx Corp  LUNG.OQ   LUNG.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 19 for
the period ending December 31 2024
    * The Redwood City California-based  company is expected to
report
a 15.6% increase in revenue to $22.291 million from $19.28
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Pulmonx Corp is for a
loss
of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$11.00​, above​ its last closing price of $6.97. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.45       -0.45      -0.36     Beat    19.7
 Jun. 30 2024  -0.42       -0.43      -0.35     Beat    17.7
 Mar. 31 2024  -0.45       -0.46      -0.36     Beat    22​
 Dec. 31 2023  -0.38       -0.41      -0.36     Beat    11.6
 ​​Sep.        -0.42       -0.43      -0.39     Beat    8.8
 30 2023                                                
 Jun. 30 2023  -0.44       -0.44      -0.43     Beat    1.6​
 Mar. 31 2023  -0.44       -0.44      -0.42     Beat    4.5
 Dec. 31 2022  -0.43       -0.42      -0.38     Beat    8.7
 This summary was machine generated February 17 at 21:43 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Pulmonx

See all news